Clinical trials
Phase 2 Endocrine System Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Terminated | 5 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| TesoRx Pharma, LLC | 2 |
| AbbVie | 1 |
| Akcea Therapeutics | 1 |
| Albert Einstein College of Medicine | 1 |
| Ascendis Pharma A/S | 1 |
| AstraZeneca | 1 |
| Calibra Medical, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
| Goldfinch Bio, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocrine System Diseases | 21 |
| Diabetes Mellitus | 9 |
| Glucose Metabolism Disorders | 7 |
| Metabolic Diseases | 6 |
| Diabetes Mellitus, Type 2 | 4 |
| Gonadal Disorders | 4 |
| Hypogonadism | 4 |
| Diabetes Complications | 3 |
| Autoimmune Diseases | 2 |
| Bone Resorption | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.